These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 17956988)

  • 1. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.
    Lahm A; Paolini C; Pallaoro M; Nardi MC; Jones P; Neddermann P; Sambucini S; Bottomley MJ; Lo Surdo P; Carfí A; Koch U; De Francesco R; Steinkühler C; Gallinari P
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17335-40. PubMed ID: 17956988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain.
    Bottomley MJ; Lo Surdo P; Di Giovine P; Cirillo A; Scarpelli R; Ferrigno F; Jones P; Neddermann P; De Francesco R; Steinkühler C; Gallinari P; Carfí A
    J Biol Chem; 2008 Sep; 283(39):26694-704. PubMed ID: 18614528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
    Jones P; Altamura S; De Francesco R; Gallinari P; Lahm A; Neddermann P; Rowley M; Serafini S; Steinkühler C
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1814-9. PubMed ID: 18308563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and -5 as the Major Binding Surface of SMRT Corepressor.
    Kim GS; Jung HE; Kim JS; Lee YC
    PLoS One; 2015; 10(7):e0132680. PubMed ID: 26161557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the class IIa histone deacetylases substrate specificity.
    Kutil Z; Meleshin M; Baranova P; Havlinova B; Schutkowski M; Barinka C
    FASEB J; 2022 May; 36(5):e22287. PubMed ID: 35349187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
    Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
    Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
    Riester D; Wegener D; Hildmann C; Schwienhorst A
    Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases.
    Meyners C; Mertens M; Wessig P; Meyer-Almes FJ
    Chemistry; 2017 Mar; 23(13):3107-3116. PubMed ID: 27922200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
    Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
    J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.
    Wang AH; Grégoire S; Zika E; Xiao L; Li CS; Li H; Wright KL; Ting JP; Yang XJ
    J Biol Chem; 2005 Aug; 280(32):29117-27. PubMed ID: 15964851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4.
    Backs J; Backs T; Bezprozvannaya S; McKinsey TA; Olson EN
    Mol Cell Biol; 2008 May; 28(10):3437-45. PubMed ID: 18332106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class IIa histone deacetylases: regulating the regulators.
    Martin M; Kettmann R; Dequiedt F
    Oncogene; 2007 Aug; 26(37):5450-67. PubMed ID: 17694086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of class IIa HDAC activities: it is not only matter of subcellular localization.
    Di Giorgio E; Brancolini C
    Epigenomics; 2016 Feb; 8(2):251-69. PubMed ID: 26791815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex.
    Hudson GM; Watson PJ; Fairall L; Jamieson AG; Schwabe JWR
    J Biol Chem; 2015 Jul; 290(29):18237-18244. PubMed ID: 26055705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora B-dependent regulation of class IIa histone deacetylases by mitotic nuclear localization signal phosphorylation.
    Guise AJ; Greco TM; Zhang IY; Yu F; Cristea IM
    Mol Cell Proteomics; 2012 Nov; 11(11):1220-9. PubMed ID: 22865920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.
    Bürli RW; Luckhurst CA; Aziz O; Matthews KL; Yates D; Lyons KA; Beconi M; McAllister G; Breccia P; Stott AJ; Penrose SD; Wall M; Lamers M; Leonard P; Müller I; Richardson CM; Jarvis R; Stones L; Hughes S; Wishart G; Haughan AF; O'Connell C; Mead T; McNeil H; Vann J; Mangette J; Maillard M; Beaumont V; Munoz-Sanjuan I; Dominguez C
    J Med Chem; 2013 Dec; 56(24):9934-54. PubMed ID: 24261862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites.
    Soriano FX; Chawla S; Skehel P; Hardingham GE
    J Neurochem; 2013 Jan; 124(1):26-35. PubMed ID: 23083128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.
    Hsu KC; Liu CY; Lin TE; Hsieh JH; Sung TY; Tseng HJ; Yang JM; Huang WJ
    Sci Rep; 2017 Jun; 7(1):3228. PubMed ID: 28607401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class IIa HDACs - new insights into their functions in physiology and pathology.
    Parra M
    FEBS J; 2015 May; 282(9):1736-44. PubMed ID: 25244360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.